Individual patient risk assessment and cost–benefit analysis of patiromer in AMBER – Authors' reply

Rajiv Agarwal, Patrick Rossignol, William B. White, Bryan Williams

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)311-312
Number of pages2
JournalThe Lancet
Issue number10247
StatePublished - Aug 1 2020

ASJC Scopus subject areas

  • Medicine(all)

Cite this